Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
(Q28186287)
scientific article (publication date: 10 July 2003)
scientific article (publication date: 10 July 2003)
Language:
Current Data About
Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P50) |
(Q47865044)
|
||||||||||||||||
| (P304) |
139-45
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
2
|
||||||||||||||||
| (P478) |
349
|
||||||||||||||||
| (P577) |
Thursday, July 10, 2003
|
||||||||||||||||
| (P921) |
(Q8277)
(Q79460)
|
||||||||||||||||
| (P1433) |
(Q582728)
|
||||||||||||||||
| (P1476) |
"Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event" (language: en)
|
||||||||||||||||
| (P2093) |
Thomas Berger
Paul Rubner
Franz Schautzer
Robert Egg
Irmgard Mayringer
Erika Dilitz
Florian Deisenhammer
Markus Reindl
|